We are live on
!
Find out more
SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
33 hedge funds and large institutions have $80M invested in scPharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 9 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
11% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 9
6% more funds holding
Funds holding: 31 → 33 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.07% less ownership
Funds ownership: 59.32% → 58.25% (-1.1%)
26% less capital invested
Capital invested by funds: $108M → $80M (-$27.9M)
Holders
33
Holders Change
+2
Holders Change %
+6.45%
% of All Funds
0.51%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
10
Reduced
9
Closed
3
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
-$19K
Top Buyers
Top Sellers
| 1 |
JGC
J. Goldman & Co
New York
|
-$2.32M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$217K |
| 3 |
E
Ergoteles
New York
|
-$180K |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$112K |
| 5 |
HF
HRT Financial
New York
|
-$107K |
